Gennex Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	524.18	75.89	202.31	142.13	74.91
Short-Term Investments	-	-	470	400	-	-
Cash & Short-Term Investments	524.18	524.18	545.89	602.31	142.13	74.91
Cash Growth	-5.67%	-3.98%	-9.37%	323.77%	89.74%	3750.73%
Accounts Receivable	-	435.57	141.61	178.11	94.17	113.13
Other Receivables	-	-	25.49	12.13	3.02	8.06
Receivables	-	435.57	225.92	224.45	122.2	121.2
Inventory	-	538.88	359.4	251.75	156.92	77.37
Prepaid Expenses	-	-	2.59	3.46	2.43	0.98
Other Current Assets	-	1,148	677.49	536.16	63.13	197.36
Total Current Assets	-	2,647	1,811	1,618	486.83	471.82
Property, Plant & Equipment	-	711.14	618.25	550.24	676.46	136.98
Long-Term Investments	-	0.1	0.1	0.1	0.1	68.27
Other Intangible Assets	-	29.41	29.41	29.41	61.08	-
Long-Term Deferred Tax Assets	-	-	1.76	2.31	1.37	-
Long-Term Deferred Charges	-	90.85	90.85	90.85	90.85	-
Other Long-Term Assets	-	8.7	8.7	8.82	6.47	3.19
Total Assets	-	3,487	2,560	2,300	1,323	680.27
Accounts Payable	-	202.99	131.59	151.8	70.78	77.41
Accrued Expenses	-	12.71	5.9	4.53	6.11	6.32
Short-Term Debt	-	-	64.01	23.73	5.29	101.24
Current Portion of Long-Term Debt	-	359.54	38.18	33.47	5.25	-
Current Income Taxes Payable	-	84.62	77.69	52.6	33.8	20.81
Other Current Liabilities	-	64.14	128.18	136.92	173.91	36.31
Total Current Liabilities	-	723.99	445.55	403.05	295.13	242.08
Long-Term Debt	-	434.07	168.93	132.16	162.88	-
Long-Term Deferred Tax Liabilities	-	0.33	-	-	-	0.03
Other Long-Term Liabilities	-	-0	0	-	-	-
Total Liabilities	-	1,158	614.48	535.21	458.01	242.11
Common Stock	-	242.95	227.45	227.45	180.19	126.5
Additional Paid-In Capital	-	-	1,002	1,002	310.7	60
Retained Earnings	-	-	568.41	405.36	303.35	242.4
Comprehensive Income & Other	-	1,982	68.79	68.79	9.25	9.25
Total Common Equity	2,225	2,225	1,867	1,704	803.5	438.15
Minority Interest	-	103.16	79	60.83	61.65	-
Shareholders' Equity	2,328	2,328	1,946	1,765	865.15	438.15
Total Liabilities & Equity	-	3,487	2,560	2,300	1,323	680.27
Total Debt	793.61	793.61	271.12	189.37	173.42	101.24
Net Cash (Debt)	-269.43	-269.43	274.78	412.94	-31.28	-26.33
Net Cash Growth	-	-	-33.46%	-	-	-
Net Cash Per Share	-0.97	-0.98	1.19	1.91	-0.20	-0.21
Filing Date Shares Outstanding	243.04	242.96	227.45	227.45	176.64	126.5
Total Common Shares Outstanding	243.04	242.96	227.45	227.45	176.64	126.5
Working Capital	-	1,923	1,366	1,215	191.7	229.74
Book Value Per Share	9.16	9.16	8.21	7.49	4.55	3.46
Tangible Book Value	2,196	2,196	1,837	1,674	742.41	438.15
Tangible Book Value Per Share	9.04	9.04	8.08	7.36	4.20	3.46
Land	-	-	118.15	109.97	114.84	84.18
Buildings	-	-	134.63	120.28	165.4	20.26
Machinery	-	-	442.8	406.79	482.89	201.7
Construction In Progress	-	-	52.17	23.25	0.21	-